会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • VACCINE IMMUNOTHERAPY
    • 疫苗免疫治疗
    • WO2008014220A2
    • 2008-01-31
    • PCT/US2007074156
    • 2007-07-24
    • IRX THERAPEUTICS INCHADDEN JOHN WSIGNORELLI KATHYEGAN JAMES
    • HADDEN JOHN WSIGNORELLI KATHYEGAN JAMES
    • A61K38/21A61K38/19A61K38/20
    • A61K39/0011A61K38/191A61K38/2006A61K38/2013A61K38/204A61K38/2053A61K38/217A61K2300/00
    • The present invention provides compositions and methods of immunotherapy to treat cancer or other antigen-producing diseases or lesions. According to one embodiment of the invention, a composition is provided for eliciting an immune response to at (east one antigen in a patient having an antigen-producing disease or lesion, the composition comprising an effective amount of a cytokine mixture, preferably comprising IL-1, IL-2, IL-6, IL-8, IFN-? (gamma) and TNF-a (alpha). The cytokine mixture acts as an adjuvant with the antigen associated with the antigen-producing disease or lesion to enhance the immune response of the patient to the antigen. Methods are therefore also provided for eliciting an immune response to at least one antigen in a patient having an antigen-producing disease or lesion utilizing the cytokine mixture of the invention. The compositions and methods are useful in the treatment of antigen-producing diseases such as cancer, infectious diseases or persistent lesions.
    • 本发明提供了用于治疗癌症或其他抗原生成疾病或损伤的免疫疗法的组合物和方法。 根据本发明的一个实施方案,提供了一种组合物,用于引发针对患有产生抗原的疾病或损伤的患者中(至少一种抗原)的免疫应答,所述组合物包含有效量的细胞因子混合物,优选包含IL- 1,IL-2,IL-6,IL-8,IFN-γ(γ)和TNF-αα。细胞因子混合物作为与产生抗原的疾病或病变相关的抗原的佐剂来增强 因此还提供了用于利用本发明的细胞因子混合物在患有抗原生成疾病或损伤的患者中引发针对至少一种抗原的免疫应答的方法,所述组合物和方法可用于 治疗产生抗原的疾病如癌症,感染性疾病或持续性病变。